Limits of Breast Cancer Screening Today
Despite widespread use of mammography, the technology has significant limits with average sensitivity of just 70% and even lower levels among women with dense breast tissue, which make up the majority of women under the age of 50. Mamography is also a painful proceedure for many women, reducing compliance among patients.
From a global perspective, outside of the US and Europe, mamograms remains outside of many healthcare baskets, due to high upfront investments hospitals must make to purchase the necessary equipment.
Latest Clinical Data
Todos Medical has collected over 1,000 clinical samples in several clinical trials for breast and other cancers at the Wolfson Medical Center (Holon, Israel), Rabin Medical Center (Petach Tikva, Israel), Ichilov Medical center (Tel Aviv, Israel) and in the Ukraine. The latest clinical trial (link to article in publication section) for Todos Medical’s breast cancer test included 59 patients and achieved 93% sensitivity and 87% specificy as compared to routine mamography screening.